Özgür KASAPÇOPUR, Kenan BARUT, Emel GÜR, Aydilek DAĞDEVİREN-ÇAKIR, Ahmet ARVAS

Serum vitamin D levels during activation and remission periods of patients with juvenile idiopathic arthritis and familial Mediterranean fever

Dağdeviren-Çakır A, Arvas A, Barut K, Gür E, Kasapçopur Ö. Serum vitamin D levels during activation and remission periods of patients with juvenile idiopathic arthritis and familial Mediterranean fever. Turk J Pediatr 2016; 58: 125-131.The aim of this study was to determine the frequency of vitamin D deficiency and/or insufficiency in children with juvenile idiopathic arthritis (JIA) and familial Mediterranean fever (FMF) and to assess the relationship between vitamin D and disease activity. Sixty four patients with JIA, thirty six patients with FMF and one hundred healthy children were enrolled in this study. Vitamin D levels were measured during activation and remission periods in the patients with JIA and during attack and attack free periods in the patients with FMF. The mean vitamin D levels were found to be 18. 9±11 ng/ml and 18.6±9.2 ng/ml during activation and remission periods of disease, respectively, in the patients with JIA, 16±8.5 ng/ml and 13.1±6.4 ng/ml during attack and attack-free periods, respectively, in the patients with FMF and 26.7±10.5 ng/ml in the healthy children. There was no significant difference between vitamin D levels during activation and remission periods in the patients with JIA, whereas vitamin D levels during attack free periods were lower compared to attack periods in the patients with FMF. No significant relationship was found between disease activity and serum vitamin D levels. The vitamin D levels of the children with JIA and FMF were significantly lower compared to the healthy children. The frequency of vitamin D deficiency and insufficiency was considerably high among the patients with JIA and FMF.

PDF

___

1. Palacios C, Gonzalez L. Is vitamin D deficiency a major global public health problem? J Steroid Biochem Mol Biol 2014; 144: 138-145.
2. Gonzalez-Gross M, Valtuena J, Breidenassel C, et al. Vitamin D status among adolescents in Europe: the healthy lifestyle in Europe by nutrition in adolescence study. Br J Nutr 2012; 107: 755-764.
3. Andıran N, Çelik N, Akça H, Doğan G. Vitamin D deficiency in children and adolescents. J Clin Res Pediatr Endocrinol 2012; 4: 25-29.
4. Akman AO, Tumer L, Hasanoglu A, Ilhan M, Caycı B. Frequency of vitamin D insufficiency in healthy children between 1and 16 years of age in Turkey. Pediatr Int 2011; 53: 968-973.
5. Cantorna MT. Mechanisms underlying the effect of vitamin D on the immune system. Proc Nutr Soc 2010; 69: 286-289.
6. Harris ED Jr, Schur PH. Pathogenesis of rheumatoid arthritis. In: Basow DS (ed). Up To-Date. Waltham, MA: Up To Date; 2007.
7. Hewison M. Vitamin D and the immune system: new perspectives on an old theme. Endocrinol Metab Clin North Am 2010; 39: 365-379.
8. Christakos S, Deluca HF. Vitamin D: is there a role in extraskeletal health? Endocrinology 2011; 152: 2930- 2936.
9. Gowdie PJ, Tse SM. Juvenile idiopathic arthritis. Pediatr Clin North Am 2012; 59: 301-327.
10. Petty RE, Cassidy JT. Chronic arthritis in childhood. In: Cassidy JT, Petty RE (ed). Textbook of Pediatric Rheumatology (5th ed). Philadelphia: Elsevier Saunders Company; 2005: 206-341.
11. Prakken B, Albani S, Martini A. Juvenile idiopathic arthritis. Lancet 2011; 377: 2138-2149.
12. Cantorna MT. Vitamin D and autoimmunity: is vitamin D status an enviromental factor affecting autoimmune disease prevalence? Proc Soc Exp Biol Med 2000; 223: 230-233.
13. Colin EM, Asmawidjaja PS, van Hamburg JP, et al. 1,25-Dihydroxyvitamin D3 modulates Th17 polarization and interleukin -22 expression by memory T cells from patients with early rheumatoid arthritis. Arthritis Rheum 2010; 62: 132-142.
14. Ozen S, Bilginer Y. A clinical guide to autoinflammatory diseases: familial Mediterranean fever and next-of-kin. Nat Rev Rheumatol 2014; 10: 135-147.
15. Erten S, Altunoglu A, Ceylan GG, Maraş Y, Koca C, Yüksel A. Low plasma vitamin D levels in patients with Familial Mediterranean Fever. Rheumatol Int 2012; 32: 3845-3849.
16. Kısacık B, Kaya S, Pehlivan Y, Tasliyurt T, Sayarlioglu M, Onat AM. Decreased vitamin D levels in patients with familial Mediterranean fever. Rheumatol Int 2013; 33: 1355-1357.
17. Onur H, Aral H, Arıca V, Bercem G, Usta M, Kasapçopur Ö. Decreased vitamin D levels in FMF patients. Pediatric Rheumatology 2013; 11(Suppl 1): A20.
18. Petty RE, Southwood TR, Manners P, et al. International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004; 31: 390-392.
19. Yalçinkaya F, Ozen S, Ozçakar ZB, et al. A new set criteria for the diagnosis of familial Mediterranean fever in childhood. Rheumatology (Oxford) 2009; 48: 395-398.
20. Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 1997; 40: 1202- 1209.
21. Misra M, Pacaud D, Petryk A, Collett-Solberg PF, Kappy M. Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society. Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics 2008; 122: 398-417.
22. Pelajo CF, Lopez JM, Kent DM, Price L, Miller LC, Hughes BD. 25-Hydroxy vitamin D levels and juvenile idiopathic arthritis: is there an association with disease activity? Rheumatol Int 2012; 32: 3923-3929.
23. Munekata RV, Terreri MT, Peracchi OA, et al. Serum 25-hydroxyvitamin D and biochemical markers of bone metabolism in patients with juvenile idiopathic arthritis. Braz J Med Biol Res 2013; 46: 98-102.
24. Bouaddi I, Rostom S, El Badri D, et al. Vitamin D concentrations and disease activity in Moroccan children with juvenile idiopathic arthritis. BMC Musculoskelet Disord 2014; 15: 115-119.
25. Baker JF, Baker DG, Toedter G, Shults J,Von Feldt JM, Leonard MB. Associations between vitamin D, disease activity and clinical response to therapy in rheumatoid arthritis. Clin Exp Rheumatol 2012; 30: 658-664.
26. Welsh P, Peters MJ, McInnes IB, et al. Vitamin D deficiency is common in patients with RA and linked to disease activity, but circulating levels are unaffected by TNF? blockade: results from a prospective cohort study. Ann Rheum Dis 2011; 70: 1165-1167.
27. Merlino LA, Curtis J, Mikuls TR, Cerhan JR, Criswell LA, Saag KG; Iowa Women Health Study. Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women Health Study. Arthritis Rheum 2004; 50: 72-77.
28. Patel S, Farragher T, Berry J, Bunn D, Silman A, Symmons D. Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis. Arthritis Rheum 2007; 56: 2143-2149.
29. Higgins MJ, Mackie SL, Thalayasingam N, Bingham SJ, Hamilton J, Kelly CA. The effect of vitamin D levels on the assessment of disease activity in rheumatoid arthritis. Clin Rheumatol 2013; 32: 863-867.
30. Turhanoğlu AD, Guler H, Yönden Z, Aslan F, Mansuroglu A, Ozer C. The relationship between vitamin D and disease activity and functional health status in rheumatoid arthritis Rheumatol Int 2011; 31: 911-914.
31. Rossini M, Maddali Bongi S, La Montagna G, et al. Vitamin D deficiency in rheumatoid arthritis: prevalence, determinants and associations with disease activity and disability. Arthritis Res Ther 2010; 12: R216.
32. Anık A, Çatlı G, Makay B, et al. Decreased vitamin D levels in children with familial Mediterranean fever. Int J Rheum Dis 2014; 17: 321-326.